|
SNUPN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59149999956476E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.98399999995891E-07 |
| Normal-vs-Stage2 |
2.464100E-03 |
| Normal-vs-Stage3 |
1.196170E-02 |
| Normal-vs-Stage4 |
1.079640E-01 |
| Stage1-vs-Stage2 |
9.865400E-01 |
| Stage1-vs-Stage3 |
4.591800E-01 |
| Stage1-vs-Stage4 |
2.929400E-01 |
| Stage2-vs-Stage3 |
5.782800E-01 |
| Stage2-vs-Stage4 |
3.022400E-01 |
| Stage3-vs-Stage4 |
5.949600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00960000026795E-07 |
| Normal-vs-AfricanAmerican |
8.190000E-04 |
| Normal-vs-Asian |
1.277630E-01 |
| Caucasian-vs-AfricanAmerican |
1.544170E-01 |
| Caucasian-vs-Asian |
4.925200E-01 |
| AfricanAmerican-vs-Asian |
8.303000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61179958269031E-10 |
| Normal-vs-Female |
2.449200E-01 |
| Male-vs-Female |
1.246790E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.200590E-01 |
| Normal-vs-Extreme_Weight |
1.75590000317527E-08 |
| Normal-vs-Obese |
1.377280E-04 |
| Normal-vs-Extreme_Obese |
1.147550E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.684300E-02 |
| Normal_Weight-vs-Obese |
2.899200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.693000E-01 |
| Extreme_Weight-vs-Obese |
6.643800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.067400E-01 |
| Obese-vs-Extreme_Obese |
9.946400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.304000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.41169999999947E-05 |
| Normal-vs-Age(61-80Yrs) |
2.56420000011026E-07 |
| Normal-vs-Age(81-100Yrs) |
1.65586999999467E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.995000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.648200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.769900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.152400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.003200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.236200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.86370000543334E-08 |
| Normal-VS-Type2 PRCC |
1.93244999999731E-05 |
| Normal-VS-KIRP CIMP |
3.451800E-01 |
| Normal-VS-Unclassified PRCC |
2.778200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.158200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.743930E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.302200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.369570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.717000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.226440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72648999999803E-05 |
| Normal-vs-N1 |
1.147200E-01 |
| Normal-vs-N2 |
3.980000E-03 |
| N0-vs-N1 |
1.080840E-01 |
| N0-vs-N2 |
6.049000E-01 |
| N1-vs-N2 |
2.590800E-01 |
|
|
